University of Queensland revealed it has generated more than 100 spinouts since 1988, with probiotic drink manufacturer Perkii becoming number 100 in 2016.

Twentyeight-Seven Therapeutics has officially launched with $65m in series A funding to commercialise oncology treatments based on research at Harvard Medical School.

Sentea has been spun out with $1.9m in seed funding to commercialise fibre optic sensor technologies that monitor engineering structures for wear and damage.

Logistics data analytics platform Locix has emerged from stealth with $20m in funding provided by investors including University of Tokyo Edge Capital.

A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.

Abigail Barrow will stand down as interim executive director of University of Massachusetts's office of technology commercialization on September 14 after three and a half years.

Existing backers AstraZeneca and Johnson & Johnson returned for a round that will advance PhaseBio's orphan disease drug pipeline, based on research from Duke University.

The cancer therapy developer has secured $120m in a convertible note offering featuring the University of California office of the chief investment officer.

Students will be able to access online entrepreneurship materials based on the Sputnik ATX accelerator, with one each year invited to sit in on Sputnik classes.

Vesalius has provided $4.7m to Forendo Pharma, whose existing shareholders also include Karolinska Development, Novartis, Novo and Merck Group.